1d
Zacks.com on MSNHOLX's New Offerings Likely to Revive Stock Amid Macro WoesHologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new ...
Explore advancements in women's health through AI, equity, and policy with Mia Keeys of Hologic on I Don’t Care.
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff ...
Based on an index by health and medical technology firm Hologic Inc and polling company Gallup, only 36% of women worldwide have been tested for high blood pressure and 19% have tested for diabetes; ...
The 4th iteration of the Hologic Global Women’s Health Index reveals only 10% of survey respondents tested for any type of ...
Hologic's strength in the molecular diagnostics wing instills optimism among investors. Yet, a dull macroeconomic environment raises concerns.
Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.
1d
Hosted on MSNHologic Stock: Analyst Estimates & RatingsMarlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, imaging ...
according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being. Hologic, Inc. (Nasdaq: HOLX), a leading women’s health ...
DAVOS, Switzerland — Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results